EUCTR2009-015537-67-DE进行中(未招募)不适用
ntersuchung der Wirksamkeit und Sicherheit von Vareniclin in der Postakutbehandlung der Alkoholabhängigkeit - eine prospektive, bizentrische, doppelblinde, placebokontrollierte, randomisierte Phase II Studie
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Alcohol dependent as defined by the criteria of Diagnostic and Statistical Manual of mental disorders (DSM IV)
- •Male and female in- or outpatients
- •Current smoker
- •Aged 18 to 65 years
- •Last consumption of alcohol 7-21 days before randomisation
- •Detoxified and free of withdrawal symptoms at randomisation
- •Sufficient knowledge of German language
- •Able to follow verbal and written instructions
- •Able to provide written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Delirium after current withdrawal, alcohol-induced dementia, Wernicke-Korsakoff syndrome
- •Severe renal insufficiency
- •Severe liver insufficiency
- •Involutary Detoxification
- •Female patients pregnant, breast feeding or fo child bearing age and not protected by medically acceptable contraception
- •Patients with clinically relevant concomitant psychiatric discorders (including a major depressive episode, psychotic discorders, antisocial personality disorder according to DSM IV in medial history)
- •Patients with an addiction or substance abuse of other addiction-inducing substances (except nicotine or cannabis) within the last 24 months before inclusion in the trial
- •Patient having a current suicide risk with a score > 6 at the suicidality item C of the M.I.N.I. international neuropsychiatric interview (MINI)
- •Patients with any clinically significant acute or chronic progressive neurological, gastrointestinal, cardiovascular, hepatic, renal, hematological, endocrine, dermatological or respiratory disease
- •Patients with a current relevant depression (Hamilton Rating Scale for Depression (German version) values = 9 or Beck Depression Inventory (German version) values = 12)
- •Patients with a history of cancer within the last five years
- •Patients with a history of stroke or myocardial infarction within the last 6 months before screening
研究者
相似试验
已完成
不适用
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertensio-I10 Essential (primary) hypertensionEssential (primary) hypertensionI10PER-078-04OVARTIS BIOSCIENSES PERU S.A.,
招募中
2 期
Investigating the effect of ((WartOver)) ointment in the treatment of skin wartsIRCT20200509047352N2Tehran University of Medical Sciences60
尚未招募
3 期
Clinical trial of Varasurf compared with CurosurfIRCT20180515039672N4Artiman Pharmed Alborz119
进行中(未招募)
1 期
This is a multicenter, double-blind, randomized study to compare the safety, effectiveness and immunogenicity (level and body resistance to drugs) of two biological drugs administered intravenously - vedolizumab (a drug not registered in pediatric patients) and infliximab (used as standard therapy) in pediatric patients with ulcerative colitis aged 6-17 years.CTIS2023-509775-16-00Instytut Pomnik Centrum Zdrowia Dziecka66
已完成
4 期
A study to compare drugs Vortioxetine and Escitalopram, used for treatment of DepressioCTRI/2019/11/022030Dr Anshul Upadhyay60
